NCT04475042View on ClinicalTrials.gov

Stratified Treatment to Ameliorate Diastolic Left Ventricular Stiffness in Heart Failure With Preserved Ejection Fraction

PHASE2UnknownINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

November 30, 2021

Study Completion Date

May 31, 2022

Conditions
Heart Failure, Diastolic
Interventions
DRUG

Dapagliflozin

10mg od

DRUG

Placebo

Placebo

Trial Locations (1)

1091

RECRUITING

OLVG, Amsterdam

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Mariëlle Scheffer

OTHER